Skip to main content
Top

Cancer Causes & Control

Issue 5/2000

Content (10 Articles)

Leptin and insulin growth factor I in relation to breast cancer (Greece)

Eleni Petridou, Yannis Papadiamantis, Christos Markopoulos, Evangelos Spanos, Nick Dessypris, Dimitrios Trichopoulos

Diet and benign ovarian tumors (United States)

Julie A. Britton, Carolyn Westhoff, Geoffrey Howe, Marilie D. Gammon

Colorectal cancer incidence in Asian migrants to the United States and their descendants

Danna M. Flood, Noel S. Weiss, Linda S. Cook, Julia C. Emerson, Stephen M. Schwartz, John D. Potter

Diet and lung cancer mortality: a 1987 National Health Interview Survey cohort study

Rosalind A. Breslow, Barry I. Graubard, Rashmi Sinha, Amy F. Subar

Leads to cancer control based on cancer patterns in a rural population in South India

R. Rajkumar, R. Sankaranarayanan, A. Esmi, R. Jayaraman, J. Cherian, D.M. Parkin

Menstrual risk factors and early-onset breast cancer

Lesley M. Butler, Nancy A. Potischman, Beth Newman, Robert C. Millikan, Donna Brogan, Marilie D. Gammon, Christine A. Swanson, Louise A. Brinton

Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States)

Ellen Kampman, Martha L. Slattery, Bette Caan, John D. Potter

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine